|
1
|
Tefferi A and Vardiman JW: Classification
and diagnosis of myeloproliferative neoplasms: The 2008 World
Health Organization criteria and point-of-care diagnostic
algorithms. Leukemia. 22:14–22. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Swerdlow SH, Campo E, Harris NL, et al:
WHO classification of tumours of haematopoietic and lymphoid
tissues. Fourth. IARC Press; Lyon: pp. 32–37. 2008
|
|
3
|
Kabutomori O, Kanakura Y and Iwatani Y:
Increase in platelet-large cell ratio in chronic myeloid leukemia.
Leuk Res. 25:8732001. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Kouides PA and Bennett JM: Morphology and
classification of myelodysplastic syndromes. Hematol Oncol Clin
North Am. 6:485–499. 1992.PubMed/NCBI
|
|
5
|
Raman BK, Van Slyck EJ, Riddle J, Sawdyk
MA, Abraham JP and Saeed SM: Platelet function and structure in
myeloproliferative disease, myelodysplastic syndrome and secondary
thrombocytosis. Am J Clin Pathol. 91:647–655. 1989.PubMed/NCBI
|
|
6
|
Rasi V and Lintula R: Platelet function in
the myelodysplastic syndromes. Scand J Haematol Suppl. 45:71–73.
1986.PubMed/NCBI
|
|
7
|
Wehmeier A, Fricke S, Scharf RE and
Schneider W: A prospective study of haemostatic parameters in
relation to the clinical course of myeloproliferative disorders.
Eur J Haematol. 45:191–197. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Shibata K, Nishimura J, Yufu Y and Nawata
H: Alterations in thrombin-induced protein tyrosine phosphorylation
of platelets from patients with chronic myelogenous leukemia. Int J
Haematol. 55:189–196. 1992.
|
|
9
|
RaszejaSpecht A, Skibowska A, Kabata J and
Hellmann A: Platelet defects in chronic myeloproliferative
disorders. Acta Haematol Pol. 25:253–260. 1994.(In Polish).
PubMed/NCBI
|
|
10
|
Popov VM, Vladareanu AM, Bumbea H, Kovacs
E, Moisescu MG, Onisai M, Iordache MM and Savopol T: Assessment of
changes in membrane properties of platelets from patients with
chronic myeloid leukaemia in different stages of the disease. Blood
Coagul Fibrinolysis. 25:142–150. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
MasonJE Jr, DeVita VT and Canellos GP:
Thrombocytosis in chronic granulocytic leukemia: Incidence and
clinical significance. Blood. 44:483–487. 1974.PubMed/NCBI
|
|
12
|
Osselaer JC, Jamart J and Scheiff JM:
Platelet distribution width for differential diagnosis of
thrombocytosis. Clin Chem. 43:1072–1076. 1997.PubMed/NCBI
|
|
13
|
Liu D, Chen Z, Xue Y, Lu D, Zhou Y, Gong
J, Wu W, Liang J, Ma Q, Pan J, et al: The significance of bone
marrow cell morphology and its correlation with cytogenetic
features in the diagnosis of MDS-RA patients. Leuk Res.
33:1029–1038. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Machlus KR and Italiano JE Jr: The
incredible journey: From megakaryocyte development to platelet
formation. J Cell Biol. 201:785–796. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Gao Y, Smith E, Ker E, Campbell P, Cheng
EC, Zou S, Lin S, Wang L, Halene S and Krause DS: Role of
RhoA-specific guanine exchange factors in regulation of endomitosis
in megakaryocytes. Dev Cell. 22:573–584. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Kleiman NS, Freedman JE, Tracy PB, Furie
BC, Bray PF, Rao SV, Phillips DR, Storey RF, Rusconi CP, French PA,
et al: Platelets: Developmental biology, physiology and
translatable platforms for preclinical investigation and drug
development. Platelets. 19:239–251. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
White MJ, Schoenwaelder SM, Josefsson EC,
Jarman KE, Henley KJ, James C, Debrincat MA, Jackson SP, Huang DC
and Kile BT: Caspase-9 mediates the apoptotic death of
megakaryocytes and platelets, but is dispensable for their
generation and function. Blood. 119:4283–4290. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Van der Lelie J and Von dem Borne AK:
Platelet volume analysis for differential diagnosis of
thrombocytosis. J Clin Pathol. 39:129–133. 1986. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zhou J, Ye Y, Zeng S, Zhou Y, Mao Z, Song
X, Ying B, Lu X, Jiang H and Wang L: Impact of JAK2 V617F mutation
on hemogram variation in patients with non-reactive elevated
platelet counts. PLoS One. 8:e578562013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Mottalib MA, Sultana TA, Khalil MI, Gan
SH, Islam MS, Choudhury S and Hossain MA: Phase distribution of
chronic myeloid leukemia in Bangladesh. BMC Res Notes. 7:1422014.
View Article : Google Scholar : PubMed/NCBI
|
